These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10363461)

  • 1. Effect of a change in third party reimbursement rate on prescription gross margin.
    Ganther JM; Kreling DH
    J Am Pharm Assoc (Wash); 1999; 39(3):346-52. PubMed ID: 10363461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
    Murry L; Gerleman B; Urick B; Urmie J
    J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing changes in third-party gross margin for a single community pharmacy.
    Urick BY; Urmie JM; Doucette WR; McDonough RP
    J Am Pharm Assoc (2003); 2014; 54(1):27-34. PubMed ID: 24362541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating a reasonable reimbursement for community pharmacies in third-party programs.
    Carroll NV
    Manag Care Interface; 1999 Feb; 12(2):73-6, 79-80. PubMed ID: 10346189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of prescription reimbursement methodologies in Japan and the United States.
    Akaho E; MacLaughlin EJ; Takeuchi Y
    J Am Pharm Assoc (2003); 2003; 43(4):519-26. PubMed ID: 12952317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating pharmacy level prescription drug acquisition costs for third-party reimbursement.
    Kreling DH; Kirk KW
    Med Care; 1986 Jul; 24(7):590-600. PubMed ID: 3523065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of insurance type with costs of dispensed drugs.
    Mott DA; Kreling DH
    Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing potential prescription reimbursement changes: estimated acquisition costs in Wisconsin.
    Kreling DH
    Health Care Financ Rev; 1989; 10(3):67-75. PubMed ID: 10313098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case study using descriptive analysis to estimate hidden costs in processing third party prescriptions.
    Herrier RN; Spencer JR; Davis CD
    J Am Pharm Assoc (Wash); 2000; 40(5):658-65. PubMed ID: 11029847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profitability, third-party reimbursement, and access to community pharmacies.
    Carroll NV; Miederhoff PA; Waters LW
    Clin Ther; 1996; 18(4):703-15; discussion 702. PubMed ID: 8879898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the impact of Medicare part D on the profitability of independent community pharmacies.
    Carroll NV
    J Manag Care Pharm; 2008 Oct; 14(8):768-79. PubMed ID: 18983206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How removing prescription drugs from reimbursement lists increases the pharmaceutical expenditures for alternatives.
    Gür Ali O; Topaler B
    Eur J Health Econ; 2011 Dec; 12(6):553-62. PubMed ID: 20717700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negotiating with third party payers: one community pharmacy's experience.
    Fridy K; DeHart RM; Monk-Tutor MR
    J Am Pharm Assoc (Wash); 2002; 42(5):780-8. PubMed ID: 12269712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the maximum allowable cost program.
    Lee AJ; Hefner D; Dobson A; Hardy R
    Health Care Financ Rev; 1983 Mar; 4(3):71-82. PubMed ID: 10309857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HEW promotes wider use of generic drugs, predicts savings under reimbursement plan.
    Hospitals; 1979 Feb; 53(3):17. PubMed ID: 759296
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in reimbursement rates and rules associated with the Medicare Prescription Drug Improvement and Modernization Act. Introduction.
    Johnson PE
    Am J Health Syst Pharm; 2006 Nov; 63(21 Suppl 7):S2-6. PubMed ID: 17057057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost and price of comparable branded and generic pharmaceuticals.
    Bloom BS; Wierz DJ; Pauly MV
    JAMA; 1986 Nov; 256(18):2523-30. PubMed ID: 3773152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does bargaining affect Medicare prescription drug plan reimbursements to independent pharmacies?
    Tang Y; Xie Y; Urmie JM; Doucette WR
    J Am Pharm Assoc (2003); 2011; 51(6):738-45. PubMed ID: 22068196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the additional costs of dispensing workers' compensation prescriptions.
    Schafermeyer KW
    Res Social Adm Pharm; 2007 Mar; 3(1):123-36. PubMed ID: 17350561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Who cares what it costs to dispense a Medicaid prescription?
    Lamphere-Thorpe JA; Johnston WP; Kilpatrick KE; Norwood GJ
    Health Care Financ Rev; 1994; 15(3):9-24. PubMed ID: 10137800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.